Pachychoroid neovasculopathy: A comparative review on pathology, clinical features, and therapy

被引:6
|
作者
Sagar, Pradeep [1 ]
Sodhi, Preetkanwar Singh [2 ]
Roy, Sangeeta [3 ]
Takkar, Brijesh [4 ,6 ]
Azad, Shorya Vardhan [5 ]
机构
[1] Sankara Eye Hosp, Dept Vitreo Retina, Shivamogga, India
[2] Sodhi Eye Hosp, Dept Vitreo Retina, Patiala, Punjab, India
[3] Susrut Eye Fdn & Res Ctr, Dept Vitreo Retina, Kolkata, West Bengal, India
[4] LV Prasad Eye Inst, Smt Kanuri Santhamma Ctr Vitreoretinal Dis, Banjara Hills, Hyderabad 500034, Telangana, India
[5] All India Inst Med Sci, Dr RP Ctr Ophthalm Sci, New Delhi, India
[6] Publ Hlth & Econ Res Ctr IHOPE, Indian Hlth Outcomes, Hyderabad, Telangana, India
基金
英国惠康基金;
关键词
Pachychoroid; pachychoroid neovasculopathy; choroidal neovascular membrane; OPTICAL COHERENCE TOMOGRAPHY; POLYPOIDAL CHOROIDAL VASCULOPATHY; CENTRAL SEROUS CHORIORETINOPATHY; INDOCYANINE GREEN VIDEOANGIOGRAPHY; VERTEPORFIN PHOTODYNAMIC THERAPY; ENDOTHELIAL GROWTH-FACTOR; DOUBLE-LAYER SIGN; MACULAR DEGENERATION; INTRAVITREAL INJECTION; SWEPT-SOURCE;
D O I
10.1177/11206721211036290
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
There have been major changes in our understanding of choroidal diseases in the last decade owing to multiple retinal and choroidal imaging related advances. A major conceptual pivot is establishment of pachychoroid and its spectrum of clinical disorders: pachychoroid pigment epitheliopathy, central serous chorioretinopathy, pachychoroid neovasculopathy, polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization, peripapillary pachychoroid syndrome, and focal choroidal excavation. However, considerable overlaps in manifestations and therapeutics of these disorders make differentiation amongst them difficult. This review is focused on pathogenesis and clinical aspects of pachychoroid neovasculopathy (PNV). Since PNV was defined as a separate entity around 5 years ago, there have been numerous contrasting observations surrounding it. We review and summarize these studies, and also compare PNV with other disorders of the pachychoroid spectrum in detail. There are important differences between etiologies of neovascular age related macular degeneration and PNV. Yet the current treatment strategies for PNV have been extrapolated from the trials for the former. Future research needs to validate this assumption with long-term results.
引用
收藏
页码:767 / 780
页数:14
相关论文
共 50 条
  • [31] A Comparative Study of Short-Term Vascular and Stromal Alterations of the Choroid Following Half-Fluence Photodynamic Therapy in Pachychoroid Neovasculopathy and Chronic Central Serous Chorioretinopathy
    Yanik, Ozge
    Demirel, Sibel
    Batioglu, Figen
    Ozmert, Emin
    LIFE-BASEL, 2022, 12 (09):
  • [32] One-Year Outcome of Combination Therapy with Full or Reduced Photodynamic Therapy and One Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy
    Sato-Akushichi, Miki
    Ono, Shinji
    Taneda, Tatsuro
    Klose, Gerd
    Sasamori, Asuka
    Song, Youngseok
    PHARMACEUTICALS, 2022, 15 (04)
  • [33] Review: The spectrum of clinical features seen with alpha synuclein pathology
    Barker, R. A.
    Williams-Gray, C. H.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2016, 42 (01) : 6 - 19
  • [34] Review: Tau in biofluids - relation to pathology, imaging and clinical features
    Zetterberg, H.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2017, 43 (03) : 194 - 199
  • [35] Ataxia-telangiectasia: A review of clinical features and molecular pathology
    Amirifar, Parisa
    Ranjouri, Mohammad Reza
    Yazdani, Reza
    Abolhassani, Hassan
    Aghamohammadi, Asghar
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2019, 30 (03) : 277 - 288
  • [36] Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes
    Nobuya Tanaka
    Keiko Azuma
    Shuichiro Aoki
    Kohdai Kitamoto
    Kohei Ueda
    Ryosuke Fujino
    Tatsuya Inoue
    Ryo Obata
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 1811 - 1818
  • [37] Vanishing pachy-choroid in pachychoroid neovasculopathy under long-term anti-vascular endothelial growth factor therapy
    Benedikt Schworm
    Nikolaus Luft
    Leonie F. Keidel
    Thomas C. Kreutzer
    Tina R. Herold
    Siegfried G. Priglinger
    Jakob Siedlecki
    BMC Ophthalmology, 21
  • [38] Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy
    Yamada, Chizu
    Mukai, Ryo
    Shinohara, Yoichiro
    Matsumoto, Hidetaka
    Akiyama, Hideo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [39] Photodynamic Therapy Increases Macular Atrophy more than Intravitreal Aflibercept at Two-Year follow-up of Pachychoroid Neovasculopathy
    Kojima, Hirokazu
    Yamashita, Ayana
    Myoshi, Yukiko
    Osaka, Rie
    Ono, Aoi
    Suzuma, Kiyoshi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [40] Changes in central and peripheral choroidal thickness after half-fluence photodynamic therapy combined with intravitreal aflibercept injection for pachychoroid neovasculopathy
    Fukuda, Yosuke
    Notomi, Shoji
    Shiose, Satomi
    Maehara, Yusuke
    Kano, Kumiko
    Hashimoto, Sawako
    Ishikawa, Keijiro
    Sonoda, Koh-Hei
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)